Alex Carchidi @AlexCarchidi

Writer, consultant, and entrepreneur. Motley Fool contributor. Boston, MA Joined July 2020

Tweets

43
Followers

493
Following

208
Likes

3K

Alex Carchidi @AlexCarchidi

3 months ago

Here's my high-level take on what's going on in crypto right now: quantumcanary.org/insights/crypt…

3 0 0 76 0

View Details

Alex Carchidi @AlexCarchidi

3 months ago

Check out my latest article for Quantum Canary about the intersection of ZK and quantum computing: quantumcanary.org/insights/zk-qu…

1 0 0 81 0

View Details

@SmallCapBob2 Tell me what you really think 😂 In all seriousness, I think NVAX has a great COVID vaccine product -- the best so far based on the data I've seen. But the longstanding manufacturing issues were resolved so late in the game that they missed the window to be a good investment.

3 0 0 83 0

View Details

Alex Carchidi @AlexCarchidi

2 years ago

@KingFranklinIV I'd attend!

0 0 1 80 0

View Details

Alex Carchidi @AlexCarchidi

3 years ago

@ira_knee So in your view, the misconduct allegations are fabricated, and CUNY's investigation is bogus? I'm struggling to understand what investors see in this company

1 0 1 65 0

View Details

Alex Carchidi @AlexCarchidi

3 years ago

@Jettyjittyjit Hi Jason -- the EPS figures are just the average analyst estimates which haven't been proven true or false yet, as they're for future years, whereas the PE figure is based on net income from the last 12 months. It has trailing 12-month EPS of $0.56.

1 0 0 57 0

View Details

Alex Carchidi @AlexCarchidi

3 years ago

@Biohazard3737 I'd join.

0 0 0 85 0

View Details

Alex Carchidi @AlexCarchidi

3 years ago

@BoldJava Glad you liked it! More to come.

1 0 0 42 0

View Details

Alex Carchidi @AlexCarchidi

3 years ago

@badri_kannan Glad you liked it! I'm still salty about it because I wish I hadn't sold

1 0 0 39 0

View Details

Alex Carchidi @AlexCarchidi

3 years ago

I recently went on the @SeekingAlpha Cannabis Investing Podcast to discuss the state of the psychedelics industry, check it out: seekingalpha.com/article/456857… $CYBN $ATAI $CMPS $SEEL

5 2 7 2K 2

View Details

Alex Carchidi @AlexCarchidi

4 years ago

@ClicksAndHisses I agree with you; this stuff never happens with reputable companies. But, I didn't want to get into the weeds of the issue in the article because I felt that it might be confusing for readers. If you can think of a pithy way to describe what happened, I'm all ears.

1 0 1 117 0

View Details

unusual_whales @unusual_whales

4 years ago

Last week, Costco, $COST, CFO Richard Galant has said that its hot dog-and-soda combo at its stores will stay at $1.50, despite months of decades-high inflation.

58 62 937 0 1

View Details

Alex Carchidi @AlexCarchidi

4 years ago

@BritGeo @DeepakChopra Congratulations!!!

0 0 0 0 0

View Details

Alex Carchidi @AlexCarchidi

4 years ago

Anyone have any thoughts on reading the Economist versus the Financial Times? Wondering whether to renew my Economist subscription.

2 0 2 0 0

View Details

Alex Carchidi @AlexCarchidi

4 years ago

@EddyElfenbein Uruguay. It's expensive, but they have attained their slice of peace on Earth.

0 0 0 0 0

View Details

Alex Carchidi @AlexCarchidi

4 years ago

Going to be publishing a few inflation-related articles soon. If anyone has any specific suggestions for angles they'd like to see, let me know!

4 0 0 0 0

View Details

Alex Carchidi @AlexCarchidi

5 years ago

@LotInLifeProd @RobertB09461202 Hopefully I'm wrong and they do actually submit for EUA this month, but they've set similar deadlines and missed them more than once before. As of October they were still dealing with purity issues, so we'll see if a month or so is enough to sort things out.

1 0 0 0 0

View Details

Alex Carchidi @AlexCarchidi

5 years ago

@lundgren7 Hi, this article politico.com/news/2021/10/1… elaborates on some of what is going on. My operative word here is "might" -- I'd love to see Novavax submit their filing promptly and get regulatory approval before 2022, but they've been optimistic (and then announced delays) before.

2 0 0 0 0

View Details

Alex Carchidi @AlexCarchidi

5 years ago

@Viscount_1 Hi, here is a good general recap: politico.com/news/2021/10/1…. I would stress that the problem here is the repeated nature of various manufacturing issues in general rather than any specific obstacles with purity. I'm confident that Novavax will figure things out in due time.